lanthanum carbonate has been researched along with Uremia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YQ; Miao, YY; Xia, M; Xu, CM; Zhu, HQ | 1 |
| Akizawa, T; Kinugasa, E; Koiwa, F; Kondo, F; Kumata, C; Mizobuchi, M; Ogata, H; Ono, N; Uda, S; Yamazaki-Nakazawa, A | 1 |
| Akhtar, J; Chen, B; Wang, H; Wang, R; Yu, C; Zhang, H; Zhao, T | 1 |
| Akhtar, J; Bing, C; Che, Y; Kezhou, Y; Rong, W; Tingting, Z | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Pratt, RD; Smyth, MD | 1 |
| Behets, GJ; Bervoets, AR; Blust, R; D'Haese, PC; Damment, SJ; Dauwe, S; De Broe, ME; Mubiana, VK; Roels, F; Schryvers, D; Verberckmoes, SC; Yang, Z | 1 |
| Benchitrit, J; Drüeke, TB; Edelman, A; Guerrera, IC; Joki, N; Jorgetti, V; Lacour, B; Machado dos Reis, L; Maizel, J; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG | 1 |
| Damment, SJ; Shen, V | 1 |
| Finch, J; Liapis, H; Slatopolsky, E | 1 |
| Damment, SJ | 1 |
| D'Haese, P; De Broe, M; Hutchison, AJ | 1 |
| Ben-Dov, IZ; Galitzer, H; Ilan, Y; Naveh-Many, T; Pappo, O; Silver, J; Sklair-Levy, M | 1 |
| Brancaccio, D; Cozzolino, M | 1 |
| Bellinghieri, G; Santoro, D; Savica, V | 1 |
| Aime, S; Canavese, C; Stratta, P | 1 |
1 review(s) available for lanthanum carbonate and Uremia
| Article | Year |
|---|---|
Emerging drugs for hyperphosphatemia.
Topics: Animals; Atherosclerosis; Calcinosis; Calcium Phosphates; Chelating Agents; Drugs, Investigational; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Saliva; Sevelamer; Uremia | 2007 |
15 other study(ies) available for lanthanum carbonate and Uremia
| Article | Year |
|---|---|
Relationship between Gut Microbiota and Phosphorus Metabolism in Hemodialysis Patients: A Preliminary Exploration.
Topics: Child; Female; Gastrointestinal Microbiome; Humans; Lanthanum; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Risk Factors; Uremia | 2018 |
Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.
Topics: Animals; Chelating Agents; Diet; Disease Models, Animal; Extracellular Matrix; Fibroblast Growth Factors; Heart Ventricles; Hyperphosphatemia; Hypertrophy, Left Ventricular; Lanthanum; Male; Nephrectomy; Parathyroid Hormone; Phosphates; Rats, Sprague-Dawley; Uremia; Ventricular Function, Left; Ventricular Remodeling | 2014 |
High phosphate feeding induced arterial medial calcification in uremic rats: roles of Lanthanum carbonate on protecting vasculature.
Topics: Animals; Calcinosis; Collagen Type II; Core Binding Factor Alpha 1 Subunit; Down-Regulation; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hyperphosphatemia; Integrin-Binding Sialoprotein; Lanthanum; Male; Osteocalcin; Phosphates; Phosphorus, Dietary; Rats; Transcription Factors; Tunica Media; Uremia | 2013 |
Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast-like activity.
Topics: Acid Phosphatase; Animals; Calcinosis; Cathepsin K; Core Binding Factor Alpha 1 Subunit; Enzyme-Linked Immunosorbent Assay; Hyperphosphatemia; Isoenzymes; Lanthanum; Osteocalcin; Osteoclasts; RANK Ligand; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tartrate-Resistant Acid Phosphatase; Uremia | 2013 |
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, Animal; Disease Progression; Fibrosis; Immunohistochemistry; Inflammation; Kidney; Kidney Failure, Chronic; Lanthanum; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Vascular Calcification | 2015 |
Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'.
Topics: Chelating Agents; Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; United States; United States Food and Drug Administration; Uremia | 2008 |
Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure.
Topics: Animals; Bile Canaliculi; Brain; Intestinal Absorption; Kidney Failure, Chronic; Lanthanum; Liver; Lysosomes; Male; Myocardium; Rats; Rats, Inbred Strains; Tissue Distribution; Uremia | 2009 |
Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Topics: Analysis of Variance; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Chemical Analysis; Bone Density; Collagen; Disease Models, Animal; Disease Progression; Female; Immunohistochemistry; Lanthanum; Mice; Mice, Inbred Strains; Polyamines; Random Allocation; Reference Values; Renal Insufficiency, Chronic; Sevelamer; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Uremia; Vascular Calcification | 2012 |
Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats.
Topics: Animals; Calcification, Physiologic; Diet; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Lanthanum; Male; Nephrectomy; Phosphates; Rats; Rats, Sprague-Dawley; Tibia; Uremia | 2005 |
Progressive accumulation of lanthanum in the liver of normal and uremic rats.
Topics: Animal Feed; Animals; Creatinine; Female; Femur; Hyperparathyroidism, Secondary; Kidney; Kidney Failure, Chronic; Lanthanum; Liver; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia | 2005 |
Enlightenment on liver lanthanum exposure.
Topics: Animal Feed; Animals; Humans; Lanthanum; Liver; Nephrectomy; Rats; Time Factors; Uremia | 2006 |
Lanthanum data in perspective.
Topics: Alanine Transaminase; Animals; Clinical Trials, Phase III as Topic; Female; gamma-Glutamyltransferase; Humans; Intestinal Absorption; Lanthanum; Liver; Male; Randomized Controlled Trials as Topic; Rats; Time Factors; Uremia | 2006 |
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats.
Topics: Animals; Biopsy; Disease Models, Animal; Disease Progression; Gene Expression; Kidney Failure, Chronic; Lanthanum; Liver; Magnetic Resonance Imaging; Male; Parathyroid Hormone; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; Uremia | 2007 |
Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
Topics: Atherosclerosis; Calcinosis; Calcium Phosphates; Chelating Agents; Drugs, Investigational; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer; Uremia | 2007 |
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate.
Topics: Chelating Agents; Contraindications; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; Skin Diseases; United States; United States Food and Drug Administration; Uremia | 2007 |